Corcept Therapeutics Inc (CORT) stock
CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/30350% above fair value
$73.71−0.82 (-1.10%)
Close on Nov 12, 2026Market cap $7.97BP/E 175.5Yield –
Corcept Therapeutics statistics
99 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 23, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 11.29
- 2.29
- P/OCF Ratio
- 72.63
- 12.93
Enterprise valuationIndustry
- EV / Sales
- 9.22
- 2.60
- EV / EBIT
- 1195.90
- 18.72
- EV / FCF
- 71.64
- 22.07
Share statisticsIndustry
- Shares Change (YoY)
- -2.32%
- 10.9%
- Float
- 93M
- 49M
- Shares Held by Insiders
- 14.4%
- 12.1%
- Shares Held by Institutions
- 76.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 9M
- –
- Short Interest Change
- 6.26%
- -0.76%
- Short % of Float
- 9.86%
- 9.04%
- Short % of Shares Outstanding
- 8.44%
- 6.30%
- Days to Cover
- 8.10
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $126.38
- –
- 52-Week Low
- $28.66
- –
- 20-Day Moving Average
- $87.95
- –
- 50-Day Moving Average
- $104.49
- –
- 200-Day Moving Average
- $76.36
- –
- Average True Range (14)
- $5.42
- –
- Price Change (1 Week)
- 2.90%
- 1.51%
- Price Change (1 Month)
- -36.6%
- -2.35%
- Price Change (3 Months)
- -35.6%
- -21.1%
- Price Change (6 Months)
- 26.4%
- -22.6%
- Price Change (YTD)
- 111.8%
- -22.6%
- Price Change (1 Year)
- -6.71%
- -20.7%
- Price Change (3 Years)
- 197.0%
- -27.4%
- Price Change (5 Years)
- 220.5%
- -77.3%
- Price Change (10 Years)
- 658.3%
- -62.7%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.68
- 0.79
- Relative Strength Index (14)
- 26.6
- 44.7
- Volatility (1 Year)
- 83.3%
- 80.4%
- Beta (5 Years)
- 0.58
- 1.07
MarginsIndustry
- Pretax Margin
- 3.17%
- -11.8%
- EBITDA Margin
- 0.97%
- -27.7%
- FCF Margin
- 12.9%
- -9.20%
Returns on capitalIndustry
- Return on Equity (ROE)
- 8.23%
- -51.2%
- Return on Assets (ROA)
- 6.53%
- -40.6%
- Return on Invested Capital (ROIC)
- 1.85%
- -32.9%
- Return on Capital Employed (ROCE)
- 0.87%
- -38.0%
Financial positionIndustry
- Current Ratio
- 2.86
- 3.30
- Quick Ratio
- 2.50
- 2.42
GrowthIndustry
- Revenue Growth (YoY)
- 16.0%
- 7.01%
- Net Income Growth (YoY)
- -58.7%
- -14.4%
- EPS Growth (YoY)
- -62.5%
- -11.7%
- FCF Growth (YoY)
- -40.8%
- 7.48%
- Revenue Growth (3Y CAGR)
- 23.7%
- 2.25%
- Revenue Growth (5Y CAGR)
- 16.6%
- 6.41%
- EPS Growth (3Y CAGR)
- -1.95%
- -0.17%
- EPS Growth (5Y CAGR)
- -0.72%
- 3.77%
EfficiencyIndustry
- Asset Turnover
- 0.98
- 0.40
- Inventory Turnover
- 1.11
- 2.73
- Revenue Per Employee
- $1.14M
- $429.29K
- Profits Per Employee
- $75.59K
- -$683.67K
- Employee Count
- 730
- 75
- WACC
- 7.90%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- $26.37M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $308.20M
- $17.46M
- Net Cash Per Share
- $2.85
- $0.72
- Equity (Book Value)
- $705.78M
- $53.27M
- Book Value Per Share
- $6.53
- $1.50
- Tangible Book Value
- $705.78M
- $26.82M
- Working Capital
- $285.87M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- -$2.78M
- -$944.00K
- FCF Per Share
- $0.99
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 0.69%
- -20.8%
- FCF Yield
- 1.34%
- -9.58%
- Buyback Yield
- 0.53%
- -0.73%
- Shareholder Yield
- 0.53%
- 0.00%
Taxes and interestIndustry
- Income Tax
- -$28.81M
- $74.00K
- Effective Tax Rate
- -109.3%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $7.85
- $19.34
- Graham Upside
- -89.3%
- -46.9%
- Altman Z-Score
- 28.51
- 0.30
- Piotroski F-Score
- 4
- 4
- Beneish M-Score
- -2.81
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CORT | S&P 500 | Difference | CORT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -39.2% | -2.7% | −36.5 pts | ||
| 3 months | -34.3% | -1.7% | −32.5 pts | ||
| Year to date | +111.8% | +11.9% | +99.9 pts | ||
| 1 year | -6.0% | +12.0% | −18.0 pts | ||
| 3 years | +194.5% | +78.2% | +116.3 pts | +43.3% | +21.2% |
| 5 years | +220.5% | +73.2% | +147.2 pts | +26.2% | +11.6% |
| 10 years | +658.3% | +309.6% | +348.7 pts | +22.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
9M CORT shares were sold short on Oct 30, 2026, up 6.3% from the previous report, or 9.86% of the shares available to trade. At recent volumes it would take 8.1 days to buy them back. Over the last 20 sessions, 50.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 9,125,717 | +6.3% | 1,125,986 | 8.1 |
| Oct 15, 2026 | 8,588,418 | +0.6% | 698,644 | 12.3 |
| Sep 30, 2026 | 8,540,393 | -8.7% | 2,389,305 | 3.6 |
| Sep 15, 2026 | 9,350,914 | -0.5% | 944,042 | 9.9 |
| Aug 31, 2026 | 9,399,154 | -3.1% | 789,538 | 11.9 |
| Aug 14, 2026 | 9,696,757 | -1.3% | 927,931 | 10.4 |
| Jul 31, 2026 | 9,819,732 | +4.0% | 1,538,603 | 6.4 |
| Jul 15, 2026 | 9,442,750 | +9.3% | 1,086,067 | 8.7 |
| Jun 30, 2026 | 8,641,452 | +0.8% | 1,027,184 | 8.4 |
| Jun 15, 2026 | 8,569,293 | -2.5% | 969,260 | 8.8 |
| May 29, 2026 | 8,793,063 | -5.6% | 1,028,716 | 8.6 |
| May 15, 2026 | 9,315,811 | -13.0% | 1,479,014 | 6.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?